Study Reveals Potential Biomarkers for Postpartum Depression Risk
Blood levels of neuroactive steroids during the third trimester of pregnancy may predict increased risk of postpartum depression, offering possibility for early intervention.
Essential Reads: Screening for Anxiety Disorders During Pregnancy and the Postpartum Period
According to a recent meta-analysis, about one out of every five women has at least one type of anxiety disorder during pregnancy or the postpartum period.
Can We Screen for Postpartum Depression Earlier?
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
Essential Reads: Mirtazapine (Remeron) and Pregnancy
While we have adequate data to support the use of SSRI and SNRI antidepressants during pregnancy, there is less data regarding other classes of antidepressants. Although we less commonly use mirtazapine in pregnancy, several studies have investigated the association between mirtazapine (Remeron) exposure during pregnancy and the risk of major congenital malformations. Risk of Congenital Malformations Danish Nationwide Cohort Study (2022): This study analyzed data from 895 pregnancies exposed to [...]
Phenomenology of Postpartum Psychosis: Preliminary Findings from MGHP3
The MGHP3 study provides key insights into the onset, duration, treatment, and characteristics of postpartum psychosis in a large, diverse cohort.
Prenatal Exposure to Cannabis and Risk of Autism in Children
Based on the findings of two meta-analyses and several large cohort studies, we cannot conclude that cannabis is “safe” for use during pregnancy. Data regarding risk for autism spectrum disorder is mixed.